pirenzepine has been researched along with Affective Disorders, Psychotic in 7 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Affective Disorders, Psychotic: Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc.
| Excerpt | Relevance | Reference |
|---|---|---|
| ", who received at least 6 weeks of add-on olanzapine treatment for psychotic mood disorders (schizoaffective disorders [bipolar and depressive type], bipolar disorders [I, II, and NOS], and major depressive disorder)." | 5.09 | Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study. ( Grace, JJ; Narendran, R; Pato, MT; Pristach, CA; Valenti, AM; Young, CM, 2001) |
| "Patients displaying a moderate-to-marked response to olanzapine were more likely to be younger; be female; receive a diagnosis of bipolar disorder; and have a shorter duration of illness, shorter length of stay prior to olanzapine, and longer duration of trial." | 3.70 | Clinical predictors of acute response with olanzapine in psychotic mood disorders. ( Berman, A; Greaney, JJ; Madrid, A; Narendran, R; Pike, S; Tohen, M; Zarate, CA, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Truöl, S | 1 |
| Von Hippel, C | 1 |
| Raape, J | 1 |
| König, F | 1 |
| Schatzberg, AF | 1 |
| Zarate, CA | 1 |
| Narendran, R | 2 |
| Tohen, M | 1 |
| Greaney, JJ | 1 |
| Berman, A | 1 |
| Pike, S | 1 |
| Madrid, A | 1 |
| Rothschild, AJ | 1 |
| Bates, KS | 1 |
| Boehringer, KL | 1 |
| Syed, A | 1 |
| Adli, M | 1 |
| Rossius, W | 1 |
| Bauer, M | 1 |
| Kane, JM | 1 |
| Young, CM | 1 |
| Valenti, AM | 1 |
| Pristach, CA | 1 |
| Pato, MT | 1 |
| Grace, JJ | 1 |
2 reviews available for pirenzepine and Affective Disorders, Psychotic
| Article | Year |
|---|---|
New approaches to managing psychotic depression.
Topics: Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinic | 2003 |
Tardive dyskinesia in affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipol | 1999 |
1 trial available for pirenzepine and Affective Disorders, Psychotic
| Article | Year |
|---|---|
Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
Topics: Adult; Affective Disorders, Psychotic; Aged; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; | 2001 |
4 other studies available for pirenzepine and Affective Disorders, Psychotic
| Article | Year |
|---|---|
[Improvement of tardive dyskinesia after treatment with olanzapine].
Topics: Affective Disorders, Psychotic; Aged; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Com | 2002 |
Clinical predictors of acute response with olanzapine in psychotic mood disorders.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Age Factors; Antipsychotic Agents; Benzodiazepine | 1998 |
Olanzapine response in psychotic depression.
Topics: Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depr | 1999 |
[Olanzapine in the treatment of depressive disorders with psychotic symptoms].
Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents | 1999 |